150,000 Workers Stage Historic Strike; Samsung Biologics Faces Shutdown

In an unprecedented move, 150,000 employees at Samsung Biologics have initiated their first-ever strike, threatening to bring operations to a complete halt. The labor action, centered on wage negotiations and bonus disputes, marks a critical juncture for the biopharmaceutical giant. The strike has raised concerns about disruptions to production lines and potential impacts on the company's stock performance. As talks continue, the industry watches closely, with implications for South Korea's biotech sector and broader economic landscape.